Companies: 10,795·Total market cap: $144.5T
Becton, Dickinson and Company

Becton, Dickinson and Company

BDXNYSEHealthcare● Active
$151.16
+$1.60(+1.07%)
Market Cap$54.8B
P/E Ratio
52W High$187.35
52W Low$127.58648
Overview

Becton, Dickinson and Company (BDX) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · BDX · as of Jun 8, 2026

Key Statistics

EPS (TTM)$3.95bdx eps ttm · bdx earnings per shareEarnings history
PE Ratio (TTM)38.3×bdx pe ratio ttm · bdx price to earningsPE Ratio deep dive
Revenue (TTM)$21.4Bbdx revenue ttm · bdx annual revenueFull revenue history
Dividend Yield2.48%does bdx pay dividends · bdx dividend yieldDividend history
Shares Outstanding286.6Mbdx shares outstanding · bdx floatShares outstanding history
Next EarningsAug 6, 2026Est.bdx earnings date · bdx next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$21.84B▲ +8.23% YoY
202320242025
becton, dickinson and company revenue · bdx revenue 2025
FY 2025Net Income$1.68B▼ 1.58% YoY
202320242025
becton, dickinson and company net income · bdx profit 2025
FY 2025EPS$5.84▼ 0.68% YoY
202320242025
bdx eps · becton, dickinson and company earnings per share 2025
TTM:Revenue: $21.36BNet Income: $1.14BEPS: $3.95View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Hold34 analystsis bdx a buy · bdx analyst rating
Strong Buy
0
Buy
16
Hold
17
Sell
1
Strong Sell
0
12-Month Price Target
$159.00Low
$151.16Current
$174.81Avg Target15.65% upside
$204.00High
bdx price target · bdx 12 month forecast

Total: 34 · Buy rate: 47.1%

The BDX analyst consensus is Hold, based on ratings from 34 Wall Street analysts over the past 3 months. The average 12-month price target is $174.81, representing +15.65% upside from the current price of $151.16.

Stock Performance

Full History
1D+1.07%
1W+4.64%
1M+1.16%
3M-9.55%
YTD-0.92%
1Y+11.46%
5Y-17.62%

About Becton, Dickinson and Company

CEOThomas E. Polen Jr.
IPO DateFeb 21, 1973
Employees70,000
CountryUS
Websitebd.com

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researche…

what is becton, dickinson and company · bdx stock overview · becton, dickinson and company company profile · who is becton, dickinson and company ceo · bdx NYSE · becton, dickinson and company headquarters · becton, dickinson and company business segments

About Stock Overview & Key Data

Becton, Dickinson and Company (BDX) is a Healthcare company in the Medical - Instruments & Supplies industry, listed on NYSE since Feb 21, 1973. As of the latest trading session, BDX stock price is $151.16, with a market capitalization of $54.8B. The stock has returned +11.46% over the past 12 months and -0.92% year-to-date.

According to 34 Wall Street analysts, the consensus rating for Becton, Dickinson and Company stock is Hold, with an average 12-month price target of $174.81. In fiscal year 2025, Becton, Dickinson and Company reported revenue of $21.8B and net income of $1.7B. For detailed data — including Becton, Dickinson and Company revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Becton, Dickinson and Company (BDX) stock price is $151.16. The stock is traded on NYSE under the ticker symbol BDX. The 52-week range is $127.59 – $187.35.

BDX stock priceBDX quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 8, 2026Not investment advice